By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Surrozen 

240 E. Grand Avenue
Second Floor
South San Francisco  California  94080  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Surrozen is discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway.

The Wnt pathway plays a critical role in stem cell maintenance, tissue regeneration and other important developmental processes. Abnormalities in the Wnt pathway have been linked to many human diseases, revealing a powerful underlying biology with relevance to a broad spectrum of organs and tissues. Surrozen is implementing a platform of “surrogate” Wnt molecules to selectively activate the Wnt pathway for the treatment of injury and disease—overcoming key hurdles that have held back industry-wide drug development efforts in this promising area of biology.

YEAR FOUNDED:

2017

LEADERSHIP:

Founders: K. Christopher Garcia, Ph.D., Roeland Nusse, Ph.D., Calvin Kuo, M.D., Ph.D. and Claudia Janda, Ph.D.,

CEO: Tim Kutzkey, Ph.D.

CSO: Wen-Chen Yeh, M.D., Ph.D.

Senior Director and Head of Discovery Biology: Yang Li, Ph.D.


Key Statistics


Email:
Ownership: Private

Web Site: Surrozen
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->